Ziopharm Oncology (United States)

Recent papers from Ziopharm Oncology (United States)

1. Inter-Rater Agreement in PD-L1 (22C3) Expression Evaluation in Colon CancerApplied immunohistochemistry & molecular morphology · 2026
2. Concept of natural genome reconstruction. Part 5. Analysis of changes in the lifespan of old animals after reinfusion of bone marrow cells derived from old animals and treated with hDNAgr in combination with recombinant human angiogeninVavilov Journal of Genetics and Breeding · 2026
3. Abstract PS3-07-23: Survivor plots for quantitated adjunctive statistically standardized ER, PgR, and HER2 in adjuvant postmenopausal breast cancer: Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozoleClinical Cancer Research · 2026
4. Concept of natural genome reconstruction. Part 3. Analysis of changes in the amount of telomeric DNA in colony cells as a new amplified feature that arose during the processing of hematopoietic bone marrow stem cellsVavilov Journal of Genetics and Breeding · 2025
5. A concept of natural genome reconstruction. Part 2. Effect of extracellular double-stranded DNA fragments on hematopoietic stem cellsVavilov Journal of Genetics and Breeding · 2025
6. A best practices framework for spatial biology studies in drug discovery and development: enabling successful cohort studies using digital spatial profilingJournal of Histotechnology · 2024
7. Understanding the financial aspects of digital pathology: A dynamic customizable return on investment calculator for informed decision-makingJournal of Pathology Informatics · 2024
8. Digitally assessed lymphocyte infiltration in rectal cancer biopsies is associated with pathological response to neoadjuvant therapyHuman Pathology · 2023
9. Comparison of Taiwanese and European Calibration Factors for Heart-to-Mediastinum Ratio in Multicenter 123I-mIBG Phantom StudiesAnnals of Nuclear Cardiology · 2023
10. Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trialNeuro-Oncology · 2021
11. Designed improvement to T-cell immunotherapy by multidimensional single cell profilingJournal for ImmunoTherapy of Cancer · 2021
12. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicityCancer Immunology Immunotherapy · 2020
13. Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymomaNeuro-Oncology · 2020
14. Very rapid cloning, expression and identifying specificity of T-cell receptors for T-cell engineeringPLoS ONE · 2020
15. Multispectral Imaging Differentiates Unique Macrophage Profiles in Patients with Distinct Chronic Liver Diseases2019
16. Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trialScience Translational Medicine · 2019
17. Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of gliomaCancer Gene Therapy · 2018
18. Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC modelsOncogene · 2018
19. Steering CAR T cells to distinguish friend from foeOncoImmunology · 2017
20. Very Rapid Production of CAR+ T-Cells upon Non-Viral Gene Transfer Using the Sleeping Beauty SystemBlood · 2016